ViaCyte, a San Diego-based company, has been working on a combination stem cell-derived product and delivery system that is aiming to treat people with insulin-dependent diabetes.
A Goal to Transform Diabetes Treatment
ViaCyte is developing a transformative cell replacement therapy to free people with insulin-requiring diabetes from painful and frequent insulin injections, strict diet regimens, constant blood sugar monitoring, and serious chronic health conditions associated with the disease.
ViaCyte, a San Diego-based company, has been working on a combination stem cell-derived product and delivery system that is aiming to treat people with insulin-dependent diabetes.
Engineering Stem Cells
ViaCyte was the first company to engineer human embryonic stem cells into definitive endoderm, the gatekeeper cells that differentiate into pancreas, liver and other cells, tissues, and organs.
ViaCyte, a San Diego-based company, has been working on a combination stem cell-derived product and delivery system that is aiming to treat people with insulin-dependent diabetes.
Becoming Islets
After 16 weeks, PEC-01 cells develop into islet-like structures.
ViaCyte, a San Diego-based company, has been working on a combination stem cell-derived product and delivery system that is aiming to treat people with insulin-dependent diabetes.
The Cells’ Transformation
The mature cells in the VC-01 combination product produce insulin, glucagon, and somatostatin.
ViaCyte, a San Diego-based company, has been working on a combination stem cell-derived product and delivery system that is aiming to treat people with insulin-dependent diabetes.
The Delivery Device
This is a cross sectional image of the cells implanted into the Encaptra, a biocompatible, immunoprotective device that will house the PEC-01 therapy. All Images are courtesy of ViaCyte. To read more about this exciting technology, check out our interview with ViaCyte’s President and CEO Paul Laikind, which can be read here:
Creating a Unique Environment and Transformative Cell Supply to Re-Ignite Insulin Production
